Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

INDUSTRY × Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 216 Neoplasms 129 Breast Neoplasms 129 Colorectal Neoplasms 90 Prostatic Neoplasms 85 Neoplasm Metastasis 79 Ovarian Neoplasms 77 Multiple Myeloma 70 Lung Neoplasms 62 Melanoma 60 Recurrence 55 Endometrial Neoplasms 55 Stomach Neoplasms 51 Pancreatic Neoplasms 47 Squamous Cell Carcinoma of Head and Neck 46 Triple Negative Breast Neoplasms 43 Leukemia, Myeloid, Acute 43 Leukemia, Lymphocytic, Chronic, B-Cell 42 Small Cell Lung Carcinoma 41 Lymphoma, Non-Hodgkin 40 Lymphoma, Follicular 38 Lymphoma, Large B-Cell, Diffuse 37 Parkinson Disease 4, Autosomal Dominant Lewy Body 34 Carcinoma, Renal Cell 34 Uterine Cervical Neoplasms 31 Urinary Bladder Neoplasms 29 Myasthenia Gravis 28 Lymphoma 28 Carcinoma, Hepatocellular 28 Head and Neck Neoplasms 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡